Skip to content

A Study of the Feasibility of Prehospital Remote Ischemic Conditioning

A Pilot Study of the Feasibility of Prehospital Delivery of Remote Ischemic Conditioning by Emergency Medical Services in Chest Pain Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03400579
Enrollment
10
Registered
2018-01-17
Start date
2018-07-10
Completion date
2019-10-01
Last updated
2020-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Pain

Keywords

Emergency Medical Services

Brief summary

Prospective, single center, single arm pilot study evaluating the feasibility of delivering remote ischemic conditioning (RIC) by emergency medical services (EMS) in the prehospital setting. Eligible patients will have chest pain or anginal equivalent symptoms and require ground ambulance transport to the hospital. All subjects will undergo the standard RIC procedure (i.e., up to four cycles of alternating 5-min inflation and 5-min deflation) with the autoRIC® device (CellAegis Devices, Inc., Toronto, Ontario). The primary objective is to evaluate the number of cycles of RIC completed in patients having the procedure initiated by EMS in the prehospital setting.

Detailed description

This single-arm, open-label pilot study will evaluate the feasibility of delivering remote ischemic conditioning (RIC) by emergency medical services (EMS) in the prehospital setting. Eligible patients will be at least 18 years of age, and require ground ambulance transport to the hospital. Patients suspected of ST-elevation myocardial infarction (STEMI) based on the prehospital electrocardiogram and thus requiring urgent intervention in the cardiac catheterization lab will be excluded. All subjects will undergo the standard RIC procedure (i.e., up to four cycles of alternating 5-min inflation and 5-min deflation) with the autoRIC® device (CellAegis Devices, Inc.). The automated procedure will be initiated by paramedics during ambulance transport, and the RIC cycles will continue through emergency department (ED) arrival and stay for a total of 40 minutes. The primary objective of this pilot study is to examine the duration of RIC administered in patients having the procedure initiated in the prehospital setting. The investigators hypothesize four cycles of RIC will be completed in at least 80% of patients having the procedure initiated. Secondary objectives are to assess enrollment rates and protocol implementation; paramedic acceptability of protocol; and patient tolerability of RIC.

Interventions

DEVICEautoRIC® device

The autoRIC® automatically delivers four RIC cycles of five minutes of pressure at 200 mm Hg followed by five minutes of no pressure for a total 40-min treatment period

Sponsors

North Carolina Translational and Clinical Sciences Institute
CollaboratorOTHER
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Prospective, single center, single arm pilot study evaluating the feasibility of delivering remote ischemic conditioning by emergency medical services during ground ambulance transport of patients experiencing chest pain or anginal equivalent symptom

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

1. Requiring 9-1-1 response to scene 2. At least 18 years of age 3. Experiencing non-traumatic chest pain or anginal equivalent symptom 4. Not meeting EMS criteria for a suspected STEMI based on prehospital ECG 5. Systolic blood pressure (SBP) between 100-180 mgm Hg 6. Designated for ambulance transport to University of North Carolina Medical Center (Chapel Hill, NC) 7. Capable of providing informed consent

Exclusion criteria

1. Unconscious or otherwise in critical condition 2. Lacking capacity to consent to the study 3. Non-English speaking 4. Pre-existing condition precluding blood pressure check or use of the autoRIC® at the discretion of the provider or listed here: 1. Paresis of upper limb 2. Pre-existing traumatic injury to arm 3. Presence of an arteriovenous shunt for dialysis 4. Prior mastectomy 5. Existing peripheral inserted central catheter line 6. Arm edema or other indication of upper extremity thrombosis 5. Serial ECG evidence of evolving STEMI

Design outcomes

Primary

MeasureTime frameDescription
Percent of Subjects Receiving 4 Cycles of RIC Without Interruptionup to 40 minutes, following initiation of RICA completed RIC cycle without interruption is defined as 5 minutes inflation followed by 5 minutes deflation for a total of 10 minutes.

Secondary

MeasureTime frameDescription
Percent of Patients Recruited Who Agreed to Participatethrough EMS transport, an average of 20 minutesParticipation among patients who are screened and recruited.
Timing (in Minutes) of Study Proceduresthrough EMS response and transport, an average of 30 minutesTimes will be reported for on-scene arrival, patient transport, screening, recruitment, and RIC initiation to assess efficiency with which the study protocol was implemented. Screening, recruitment and RIC initiation times are overlapping with transport time.
Percent of Patients Screened Who Are Eligible for Recruitmentthrough EMS transport, an average of 20 minutesEligibility among patients screened and specifying inclusion and exclusion criteria met or not met.
Percent of Participants Experiencing Anticipated Adverse Events Including RIC Discontinuation Due to Discomfortup to 48 hours from end of RICAnticipated adverse events related to RIC including minor arm discomfort, temporary discoloration of the arm or hand, and minor skin bruising or abrasions on the upper arm will be collected via in-person and telephone evaluation.
Themes on Patient Experiences While Undergoing RICup to 15 minutesQualitative themes related to the RIC procedure will be derived from semi-structured interviews with subjects.
Themes on Paramedic Acceptability of the Study Protocolup to 15 minutes from screeningQualitative themes related to implementation of the study protocol will be derived from semi-structured interviews with study paramedics.

Countries

United States

Participant flow

Participants by arm

ArmCount
Remote Ischemic Conditioning
RIC procedure (i.e., four cycles of alternating 5-min inflation and 5-min deflation) administered by the autoRIC® device autoRIC® device: The autoRIC® automatically delivers four RIC cycles of five minutes of pressure at 200 mm Hg followed by five minutes of no pressure for a total 40-min treatment period
10
Total10

Baseline characteristics

CharacteristicRemote Ischemic Conditioning
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
1 Participants
Age, Categorical
Between 18 and 65 years
9 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
10 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
6 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
4 Participants
Region of Enrollment
United States
10 Participants
Sex/Gender, Customized
Female
8 Participants
Sex/Gender, Customized
Male
2 Participants
Systolic Blood Pressure (mmHg)
100-120
3 Participants
Systolic Blood Pressure (mmHg)
121-140
2 Participants
Systolic Blood Pressure (mmHg)
141-160
4 Participants
Systolic Blood Pressure (mmHg)
161-180
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 10
other
Total, other adverse events
0 / 10
serious
Total, serious adverse events
0 / 10

Outcome results

Primary

Percent of Subjects Receiving 4 Cycles of RIC Without Interruption

A completed RIC cycle without interruption is defined as 5 minutes inflation followed by 5 minutes deflation for a total of 10 minutes.

Time frame: up to 40 minutes, following initiation of RIC

ArmMeasureValue (NUMBER)
Remote Ischemic ConditioningPercent of Subjects Receiving 4 Cycles of RIC Without Interruption80 percentage of participants
Secondary

Percent of Participants Experiencing Anticipated Adverse Events Including RIC Discontinuation Due to Discomfort

Anticipated adverse events related to RIC including minor arm discomfort, temporary discoloration of the arm or hand, and minor skin bruising or abrasions on the upper arm will be collected via in-person and telephone evaluation.

Time frame: up to 48 hours from end of RIC

ArmMeasureValue (NUMBER)
Remote Ischemic ConditioningPercent of Participants Experiencing Anticipated Adverse Events Including RIC Discontinuation Due to Discomfort0 percentage of participants
Secondary

Percent of Patients Recruited Who Agreed to Participate

Participation among patients who are screened and recruited.

Time frame: through EMS transport, an average of 20 minutes

Population: Among all patients screened and determined to be eligible

ArmMeasureValue (NUMBER)
Remote Ischemic ConditioningPercent of Patients Recruited Who Agreed to Participate91 percentage of patients recruited
Secondary

Percent of Patients Screened Who Are Eligible for Recruitment

Eligibility among patients screened and specifying inclusion and exclusion criteria met or not met.

Time frame: through EMS transport, an average of 20 minutes

Population: Includes all patients screened for study eligibility

ArmMeasureValue (NUMBER)
Remote Ischemic ConditioningPercent of Patients Screened Who Are Eligible for Recruitment100 percentage of patients screened
Secondary

Themes on Paramedic Acceptability of the Study Protocol

Qualitative themes related to implementation of the study protocol will be derived from semi-structured interviews with study paramedics.

Time frame: up to 15 minutes from screening

Population: The overall number of participants analyzed reflects participants undergoing the intervention (i.e., Remote Ischemic Conditioning). The study paramedics administering the intervention were not considered enrolled but contributed data for this assessment.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Remote Ischemic ConditioningThemes on Paramedic Acceptability of the Study ProtocolNot enough time4 Participants
Remote Ischemic ConditioningThemes on Paramedic Acceptability of the Study ProtocolDifficult to size the cuff4 Participants
Remote Ischemic ConditioningThemes on Paramedic Acceptability of the Study ProtocolOngoing training needed3 Participants
Secondary

Themes on Patient Experiences While Undergoing RIC

Qualitative themes related to the RIC procedure will be derived from semi-structured interviews with subjects.

Time frame: up to 15 minutes

Population: Includes participants that completed at least two RIC cycles

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Remote Ischemic ConditioningThemes on Patient Experiences While Undergoing RICFelt like a blood pressure cuff5 Participants
Remote Ischemic ConditioningThemes on Patient Experiences While Undergoing RICFelt tight4 Participants
Secondary

Timing (in Minutes) of Study Procedures

Times will be reported for on-scene arrival, patient transport, screening, recruitment, and RIC initiation to assess efficiency with which the study protocol was implemented. Screening, recruitment and RIC initiation times are overlapping with transport time.

Time frame: through EMS response and transport, an average of 30 minutes

ArmMeasureGroupValue (MEAN)Dispersion
Remote Ischemic ConditioningTiming (in Minutes) of Study ProceduresOn-Scene Time22.5 minutesStandard Deviation 5.6
Remote Ischemic ConditioningTiming (in Minutes) of Study ProceduresScreening Time9.4 minutesStandard Deviation 10
Remote Ischemic ConditioningTiming (in Minutes) of Study ProceduresRecruitment and RIC Start Time4.4 minutesStandard Deviation 8.7
Remote Ischemic ConditioningTiming (in Minutes) of Study ProceduresTransport Time9.2 minutesStandard Deviation 4.6

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026